Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity
Authors:
- 1 September 1993
- journal article
- Published by Elsevier in Journal of Virological Methods
- Vol. 44 (1) , 11-23
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Avidity of IgG antibodies to human herpesvirus‐6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross‐reactivity with other herpesvirusesJournal of Medical Virology, 1993
- Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease.BMJ, 1990
- Antigenic parvovims B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression systemVirus Research, 1990
- Immunoglobulin G avidity in Epstein-Barr virus infections in organ transplant recipientsSerodiagnosis and Immunotherapy in Infectious Disease, 1989
- Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin TherapyNew England Journal of Medicine, 1989
- SEROLOGICAL DISTINCTION BETWEEN PRIMARY RUBELLA AND REINFECTIONThe Lancet, 1988
- RUBELLA INFECTION AND REINFECTION DISTINGUISHED BY AVIDITY OF IgGThe Lancet, 1988
- HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTIONThe Lancet, 1985
- A search for a characteristic illness in children with serological evidence of viral or toxoplasma infection: Epstein Barr Virus, Hepatitis A, Human Polyomaviruses BK and JC, Parvovirus-like B19 and ToxoplasmaJournal of Infection, 1981
- Description of a technique for the determination of the concentration and quality of rubella virus antibody molecules and experience with testing sera from humans with recent and past rubella infectionArchives of Virology, 1980